Journal of Natural Products · 2018 · 29 citations · 28 references
PharmacyChemistryMedicinal ChemistryDrug DiscoveryNatural Product BiosynthesisSynthetic Medicinal ChemistryAntifungal AgentsNatural Product Drug DiscoveryRetrosynthetic AnalysisDecarboxylative CouplingMacrocyclic Natural ProductsMedicinal Chemistry ApplicationsNatural Antifungal CompoundsNatural Product SynthesisNew Antifungal AgentsNovel Antifungal Drug Development
The efficient synthesis and antifungal exploration of (+)-yahazunol and related natural products are described. Central to this strategy is the Barton decarboxylative coupling, comprising a one-pot radical decarboxylation and quinone addition cascade. The scalable synthesis of (+)-yahazunol was accomplished in five longest linear sequences (LLS) starting from commercially available and inexpensive (−)-sclareol. The divergent translational potential of (+)-yahazunol was demonstrated by the expedient preparation of (−)-zonarone, (−)-isozonarone, (−)-zonarol, (−)-isozonarol, (+)-chromazonarol, and (+)-yahazunone. This approach also enables the formal synthesis of puupehenol, puupehedione, and hongoquercin A. Antifungal evaluation was performed, and this represents the first biological profiles for (+)-yahazunone, (+)-8-O-acetylyahazunone, and (+)-8-O-acetylyahazunol. (+)-Chromazonarol and (+)-yahazunone are promising candidates against Sclerotinia scleotiorum, with EC50 values of 24.1 and 28.7 μM, respectively, demonstrating advantages over the original model (DM) and synthesized heterocyclic mimic (3a) of meroterpenoids. This will favor the establishment of a chemical repertoire in the management of different plant diseases.
28
Hideaki Ishibashi, Kazuaki Ishihara, Hisashi Yamamoto · Journal of the American Chemical Society · 2004 · 175 citations
Anne M. Caniard, Philipp Zerbe, Sylvain Legrand et al. · BMC Plant Biology · 2012 · 169 citations · Full text